Baldwin Investment Management LLC Lowers Holdings in Danaher Co. (NYSE:DHR)

Baldwin Investment Management LLC reduced its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 15.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,388 shares of the conglomerate's stock after selling 2,538 shares during the period. Baldwin Investment Management LLC's holdings in Danaher were worth $3,073,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Kentucky Retirement Systems Insurance Trust Fund lifted its holdings in shares of Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after acquiring an additional 2,202 shares during the period. FAS Wealth Partners Inc. grew its stake in shares of Danaher by 20.6% in the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after purchasing an additional 1,639 shares during the last quarter. ORG Partners LLC increased its stake in shares of Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after buying an additional 2,559 shares during the period. Generate Investment Management Ltd acquired a new stake in Danaher during the 4th quarter valued at approximately $8,044,000. Finally, Compass Capital Management Inc. raised its stake in Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock worth $54,615,000 after buying an additional 10,994 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 11.10% of the company's stock.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research analyst reports. UBS Group cut their price target on shares of Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Guggenheim restated a "buy" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. lowered their target price on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Citigroup restated a "buy" rating on shares of Danaher in a report on Monday, April 7th. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $264.40.

Danaher Stock Performance

DHR stock traded up $3.05 during midday trading on Wednesday, hitting $193.10. The company's stock had a trading volume of 2,762,134 shares, compared to its average volume of 3,383,353. The stock's 50-day moving average price is $199.23 and its 200 day moving average price is $220.68. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a market cap of $138.19 billion, a price-to-earnings ratio of 36.57, a PEG ratio of 2.66 and a beta of 0.80. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, equities analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.66%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.